Clinical Trial Update: Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating cyclophosphamide, fludarabine phosphate, aldesleukin, and treated blood cells in various cancers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Aldesleukin (interleukin-2)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Cancer Research UK | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: TERMINATED